A M Gray

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi request reprint Quality of life outcomes following surgical treatment of Parkinson's disease
    Alastair Gray
    Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford, United Kingdom
    Mov Disord 17:68-75. 2002
  2. ncbi request reprint ALS/MND and the perspective of health economics
    A M Gray
    Health Economics Research Centre, University of Oxford, Institute of Health Sciences, Headington, UK
    J Neurol Sci 160:S2-5. 1998
  3. pmc Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63)
    Alastair Gray
    Health Economics Research Centre, Department of Public Health, University of Oxford, Institute of Health Sciences, Oxford OX3 7LF
    BMJ 325:860. 2002
  4. ncbi request reprint An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54)
    A Gray
    Health Economics Research Centre, Department of Public Health, University of Oxford, Institute of Health Sciences, Headington, Oxford OX3 7LF, UK
    Diabet Med 18:438-44. 2001
  5. ncbi request reprint Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72)
    P M Clarke
    Health Economics Research Centre, Department of Public Health, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK
    Diabetologia 48:868-77. 2005
  6. ncbi request reprint Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51)
    P Clarke
    Health Economics Research Centre, Department of Public Health, University of Oxford, Institute of Health Sciences, Headington, Oxford OX3 7LF, UK
    Diabetologia 44:298-304. 2001
  7. ncbi request reprint Cost effectiveness analysis of radon remediation programmes
    C A Kennedy
    Health Economics Research Centre, Institute of Health Sciences, University of Oxford, UK
    Sci Total Environ 272:9-15. 2001
  8. pmc Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation
    E Grunfeld
    Division of Public Health and Primary Health Care, Institute of Health Sciences, University of Oxford, UK
    Br J Cancer 79:1227-33. 1999
  9. doi request reprint Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial
    A J Farmer
    Department of Primary Health Care, NIHR School of Primary Care Research, University of Oxford, UK
    Health Technol Assess 13:iii-iv, ix-xi, 1-50. 2009
  10. doi request reprint The economic analyses of the UK prospective diabetes study
    A M Gray
    Health Economics Research Centre, Department of Public Health, University of Oxford, UK
    Diabet Med 25:47-51. 2008

Detail Information

Publications55

  1. ncbi request reprint Quality of life outcomes following surgical treatment of Parkinson's disease
    Alastair Gray
    Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford, United Kingdom
    Mov Disord 17:68-75. 2002
    ..Quality of life in patients with advanced Parkinson's disease is amenable to measurement; such measurement provides tentative evidence of significant gains in quality of life following some neurosurgical procedures...
  2. ncbi request reprint ALS/MND and the perspective of health economics
    A M Gray
    Health Economics Research Centre, University of Oxford, Institute of Health Sciences, Headington, UK
    J Neurol Sci 160:S2-5. 1998
    ..Meanwhile, better information on costs is required in order to produce more precise estimates of cost-effectiveness...
  3. pmc Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63)
    Alastair Gray
    Health Economics Research Centre, Department of Public Health, University of Oxford, Institute of Health Sciences, Oxford OX3 7LF
    BMJ 325:860. 2002
    ..To estimate the incremental cost of implementing policies for intensive control of blood glucose concentration and blood pressure for all patients with type 2 diabetes in England...
  4. ncbi request reprint An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54)
    A Gray
    Health Economics Research Centre, Department of Public Health, University of Oxford, Institute of Health Sciences, Headington, Oxford OX3 7LF, UK
    Diabet Med 18:438-44. 2001
    ..To compare the net cost of a tight blood pressure control policy with an angiotensin converting enzyme inhibitor (captopril) or beta blocker (atenolol) in patients with Type 2 diabetes...
  5. ncbi request reprint Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72)
    P M Clarke
    Health Economics Research Centre, Department of Public Health, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK
    Diabetologia 48:868-77. 2005
    ....
  6. ncbi request reprint Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51)
    P Clarke
    Health Economics Research Centre, Department of Public Health, University of Oxford, Institute of Health Sciences, Headington, Oxford OX3 7LF, UK
    Diabetologia 44:298-304. 2001
    ....
  7. ncbi request reprint Cost effectiveness analysis of radon remediation programmes
    C A Kennedy
    Health Economics Research Centre, Institute of Health Sciences, University of Oxford, UK
    Sci Total Environ 272:9-15. 2001
    ..Finally, by evaluating the radon remediation programmes using methods applied to other health interventions (such as lung cancer prevention interventions), comparisons using the same metric can be made across policy areas...
  8. pmc Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation
    E Grunfeld
    Division of Public Health and Primary Health Care, Institute of Health Sciences, University of Oxford, UK
    Br J Cancer 79:1227-33. 1999
    ..Data are provided on the average frequency and length of visits, and frequency of diagnostic testing for breast cancer patients during the follow-up period...
  9. doi request reprint Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial
    A J Farmer
    Department of Primary Health Care, NIHR School of Primary Care Research, University of Oxford, UK
    Health Technol Assess 13:iii-iv, ix-xi, 1-50. 2009
    ....
  10. doi request reprint The economic analyses of the UK prospective diabetes study
    A M Gray
    Health Economics Research Centre, Department of Public Health, University of Oxford, UK
    Diabet Med 25:47-51. 2008
    ..The analyses also illustrated a number of methodological innovations. Finally, the UKPDS Outcomes Model is gaining widespread acceptance as a validated tool for long-term economic and clinical prediction in diabetes...
  11. pmc An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom
    H E Campbell
    Department of Public Health, Health Economics Research Centre, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK
    Br J Cancer 101:1074-84. 2009
    ..It was developed in the United States, has been successfully validated in Canada, and is used in the United Kingdom and elsewhere. This study investigates the performance of Adjuvant! in a cohort of patients from the United Kingdom...
  12. ncbi request reprint Problems in conducting economic evaluations alongside clinical trials. Lessons from a study of case management for people with mental disorders
    A M Gray
    Wolfson College, University of Oxford
    Br J Psychiatry 170:47-52. 1997
    ..Here we compare the costs and cost consequences of this intervention with standard care...
  13. ncbi request reprint Deletion of glutamate receptor-A (GluR-A) AMPA receptor subunits impairs one-trial spatial memory
    D J Sanderson
    Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom
    Behav Neurosci 121:559-69. 2007
    ..5 or 5 min). These results imply that the SWM deficit in GluR-A-/- mice is not due to increased susceptibility to proactive interference...
  14. pmc Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis
    S Shepperd
    Division of Public Health and Primary Health Care, University of Oxford, Institute of Health Sciences, Headington, Oxford OX3 7LF
    BMJ 316:1791-6. 1998
    ..To examine the cost of providing hospital at home in place of some forms of inpatient hospital care...
  15. ncbi request reprint The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)
    P Clarke
    Health Economics Research Centre and Diabetes Trials Unit, University of Oxford, Oxford, UK
    Diabet Med 20:442-50. 2003
    ..To develop a model for estimating the immediate and long-term healthcare costs associated with seven diabetes-related complications in patients with Type 2 diabetes participating in the UK Prospective Diabetes Study (UKPDS)...
  16. pmc Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group
    A Gray
    Health Economics Research Centre, Department of Public Health, University of Oxford, Institute of Health Sciences, Headington OX3 7LF
    BMJ 320:1373-8. 2000
    ..To estimate the cost effectiveness of conventional versus intensive blood glucose control in patients with type 2 diabetes...
  17. pmc The economic burden of coronary heart disease in the UK
    J L Y Liu
    Health Economics Research Centre, Institute of Health Sciences, University of Oxford, Oxford, UK
    Heart 88:597-603. 2002
    ..To estimate the economic burden of coronary heart disease in the UK using both direct and indirect costs...
  18. ncbi request reprint Life-expectancy projection by modelling and computer simulation (UKPDS 46)
    R Stevens
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Infirmary, Woodstock Road, OX2 6HE, Oxford, UK
    Diabetes Res Clin Pract 50:S5-13. 2000
    ....
  19. pmc The hip trial: psychosocial consequences for mothers of using ultrasound to manage infants with developmental hip dysplasia
    F Gardner
    Department of Social Policy and Social Work, University of Oxford, UK
    Arch Dis Child Fetal Neonatal Ed 90:F17-24. 2005
    ....
  20. pmc Randomised controlled trial comparing hospital at home care with inpatient hospital care. I: three month follow up of health outcomes
    S Shepperd
    Division of Public Health and Primary Health Care, University of Oxford, Institute of Health Sciences, Headington, Oxford OX3 7LF
    BMJ 316:1786-91. 1998
    ..To compare hospital at home care with inpatient hospital care in terms of patient outcomes...
  21. pmc Cost of cardiovascular diseases in the United Kingdom
    R Luengo-Fernandez
    Health Economics Research Centre, Department of Public Health, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK
    Heart 92:1384-9. 2006
    ..To estimate the economic burden of cardiovascular disease (CVD) in the United Kingdom, including health and non-healthcare costs, and the proportion of total CVD cost due to coronary heart disease (CHD) and cerebrovascular disease...
  22. ncbi request reprint A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
    P M Clarke
    Health Economics Research Centre, Department of Public Health, University of Oxford, Headington, Oxford, UK
    Diabetologia 47:1747-59. 2004
    ....
  23. pmc A cost-effectiveness analysis of a residential radon remediation programme in the United Kingdom
    C A Kennedy
    Health Economics Research Centre, Institute of Health Sciences, University of Oxford, UK
    Br J Cancer 81:1243-7. 1999
    ..Questions are raised about the particular importance of perspective in this type of analysis and suggestions are made for future research directions...
  24. ncbi request reprint Estimating the relationship between disease progression and cost of care in dementia
    J Wolstenholme
    Health Economics Research Centre, University of Oxford, Headington, UK
    Br J Psychiatry 181:36-42. 2002
    ..Previous studies have shown a positive relationship between disease severity and cost...
  25. pmc Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK
    H E Campbell
    Health Economics Research Centre, Department of Public Health, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK
    Br J Cancer 103:776-86. 2010
    ....
  26. doi request reprint The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses
    H E Campbell
    Health Economics Research Centre, University of Oxford, Headington, Oxford, United Kingdom
    Eur J Cancer 47:2517-30. 2011
    ..These adjuvant chemotherapy regimens were used in three large UK-led randomised controlled trials (RCTs)...
  27. ncbi request reprint Costs of chemotherapy for indolent follicular non-Hodgkin's lymphoma in the UK: an observational study
    Julia Hutchinson
    Fourth Hurdle Consulting, London, UK
    Acta Haematol 115:28-34. 2006
    ..The study found the cost of providing treatment with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) or fludarabine to patients with indolent follicular NHL to be lower than previously reported...
  28. ncbi request reprint Economic burden of cardiovascular diseases in the enlarged European Union
    Jose Leal
    Department of Public Health, Health Economics Research Centre, Oxford University, Old Road Campus, Oxford OX3 7LF, UK
    Eur Heart J 27:1610-9. 2006
    ....
  29. ncbi request reprint Responsiveness of objective, disease-specific, and generic outcome measures in patients with chronic low back pain: an assessment for improving, stable, and deteriorating patients
    Helen Campbell
    Health Economics Research Centre, Department of Public Health, University of Oxford, United Kingdom
    Spine (Phila Pa 1976) 31:815-22. 2006
    ..Analysis of outcome data collected prospectively from 250 patients recruited to the UK Spine Stabilization Trial...
  30. ncbi request reprint Cost-utility analysis of physiotherapy treatment compared with physiotherapy advice in low back pain
    Oliver Rivero-Arias
    Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford, United Kingdom
    Spine (Phila Pa 1976) 31:1381-7. 2006
    ..Economic evaluation alongside a pragmatic multicenter randomized controlled trial from the National Health Service (NHS) and societal perspective...
  31. ncbi request reprint Systematic review of resource utilization in the hospital management of deliberate self-harm
    Julia M A Sinclair
    Centre for Suicide Research, Warneford Hospital, University of Oxford, UK
    Psychol Med 36:1681-93. 2006
    ..While clinical guidelines suggest good practice for the short-term hospital management of DSH, there remains considerable variability in the way that services are provided...
  32. pmc Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
    Judit Simon
    Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford OX3 7LF
    BMJ 336:1177-80. 2008
    ....
  33. ncbi request reprint Treatment pathways, resource use, and costs of endovascular coiling versus surgical clipping after aSAH
    Jane Wolstenholme
    Health Economics Research Centre, Department of Public Health, University of Oxford, Old Road Campus, Oxford, OX3 7LF UK
    Stroke 39:111-9. 2008
    ..To examine this assumption and provide evidence for future policy, accurate and comprehensive data are required on the overall resource usage and cost of each strategy...
  34. ncbi request reprint Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes
    Andrew J Palmer
    CORE Center for Outcomes Research, A Unit of IMS Health, Binningen, Switzerland
    Curr Med Res Opin 22:861-72. 2006
    ..4% when compared to no SMBG. However, the cost of testing supplies is high, improvements in health utility due to improved glycaemic control may be possible and cost-effectiveness has not been evaluated...
  35. pmc Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies
    Rosa Legood
    Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford OX3 7LF
    BMJ 332:79-85. 2006
    ..To predict the incremental lifetime effects, costs, and cost effectiveness of using human papillomavirus testing to triage women with borderline or mildly dyskaryotic cervical smear results for immediate colposcopy...
  36. pmc Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study
    Sue Moss
    Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey SM2 5NG
    BMJ 332:83-5. 2006
    ..To assess the effect of introducing testing for human papillomavirus combined with liquid based cytology in women with low grade cytological abnormalities...
  37. ncbi request reprint Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)
    Philip Clarke
    Med Decis Making 22:340-9. 2002
    ..The aim of this study was to analyze quality-of-life data from the United Kingdom Prospective Diabetes Study (UKPDS) to estimate the impact of diabetes-related complications on utility-based measures of quality of life...
  38. ncbi request reprint Ultrasonography in the diagnosis and management of developmental hip dysplasia (UK Hip Trial): clinical and economic results of a multicentre randomised controlled trial
    Diana Elbourne
    Medical Statistics Unit, London School of Hygiene and Tropical Medicine, UK
    Lancet 360:2009-17. 2002
    ..Our objectives were to assess clinical effectiveness and net cost of ultrasonography compared with clinical assessment alone, to provide guidance for management of infants with clinical hip instability...
  39. ncbi request reprint Reporting the cost-effectiveness of interventions with nonsignificant effect differences: example from a trial of secondary prevention of coronary heart disease
    Katharine Johnston
    Health Economics Research Centre, University of Oxford, Institute of Health Sciences, Headington, UK
    Int J Technol Assess Health Care 19:476-89. 2003
    ..This study reports the cost-effectiveness of interventions with nonsignificant differences in effect, and considers reporting of cost-effectiveness in situations where nonsignificant differences arise in some but not all end points...
  40. ncbi request reprint Estimating the costs of surgical innovations: the case for subthalamic nucleus stimulation in the treatment of advanced Parkinson's disease
    Emma McIntosh
    University of Oxford, Institute of Health Sciences, Oxford, United Kingdom
    Mov Disord 18:993-9. 2003
    ..Providing an estimate of the cost of this new procedure will provide a baseline for tracking future changes in costs and will assist the production of cost-effectiveness estimates...
  41. ncbi request reprint The impact of ageing on expenditures in the National Health Service
    Meena Seshamani
    Health Economics Research Centre, University of Oxford, Oxford, UK
    Age Ageing 31:287-94. 2002
    ..Documentation of such trends is essential for more accurate projection of health expenditures...
  42. ncbi request reprint Ageing and health-care expenditure: the red herring argument revisited
    Meena Seshamani
    University of Pennsylvania School of Medicine, Philadelphia, USA
    Health Econ 13:303-14. 2004
    ..The analyses show the importance of model selection to properly assess the determinants of health-care expenditures...
  43. ncbi request reprint Cancer funding throughout the world
    Mark McCarthy
    Department of Public Health, University College London, UK
    Lancet Oncol 5:453-7. 2004
  44. ncbi request reprint Time to death and health expenditure: an improved model for the impact of demographic change on health care costs
    Meena Seshamani
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Age Ageing 33:556-61. 2004
    ..Thus far, expenditure projections have examined the effect of age on health care costs, but fail to account for the influence of remaining life expectancy on costs...
  45. ncbi request reprint Economic evaluation of ultrasonography in the diagnosis and management of developmental hip dysplasia in the United Kingdom and Ireland
    Alastair Gray
    Department of Public Health, Health Economics Research Centre, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, United Kingdom
    J Bone Joint Surg Am 87:2472-9. 2005
    ..The aim of this study was to assess these costs in association with the use of ultrasonography for the diagnosis and management of neonatal hip instability...
  46. pmc Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial
    Oliver Rivero-Arias
    Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford OX3 7LF
    BMJ 330:1239. 2005
    ..To determine whether, from a health provider and patient perspective, surgical stabilisation of the spine is cost effective when compared with an intensive programme of rehabilitation in patients with chronic low back pain...
  47. ncbi request reprint Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals
    Borislava Mihaylova
    Lancet 365:1779-85. 2005
    ..Statin therapy reduces the rates of heart attack, stroke, and revascularisation among a wide range of individuals. Reliable assessment of its cost-effectiveness in different circumstances is needed...
  48. pmc Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study
    Esther Maissi
    Health Psychology Section, Psychology Department, Institute of Psychiatry, King s College London, London SE1 9RT
    BMJ 328:1293. 2004
    ..To describe the psychological impact on women of being tested for human papillomavirus (HPV) when smear test results are borderline or mildly dyskaryotic...
  49. ncbi request reprint Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial
    Judit Simon
    Health Economics Research Centre, Department of Public Health, University of Oxford, UK
    BJOG 113:144-51. 2006
    ..To assess the cost-effectiveness of using magnesium sulphate for pre-eclampsia to prevent eclampsia...
  50. ncbi request reprint Suspected adverse reactions, 2002
    Alastair Gray
    Vet Rec 153:251-4. 2003
  51. ncbi request reprint Health care expenditures and ageing: an international comparison
    Meena Seshamani
    Health Economics Research Centre, University of Oxford, Old Road, Headington, Oxford OX3 7LF, UK
    Appl Health Econ Health Policy 2:9-16. 2003
    ..These differential changes in costs for older age groups over time invite future research into the driving forces behind these costs...
  52. pmc Could targeted food taxes improve health?
    Oliver Mytton
    Queen s Medical Centre, Nottingham NG7 2UH, UK
    J Epidemiol Community Health 61:689-94. 2007
    ..To examine the effects on nutrition, health and expenditure of extending value added tax (VAT) to a wider range of foods in the UK...
  53. pmc Making amends for negligence
    Paul Fenn
    BMJ 328:417-8. 2004
  54. pmc Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people
    Borislava Mihaylova
    BMJ 333:1145. 2006
    ..To evaluate the cost effectiveness of 40 mg simvastatin daily continued for life in people of different ages with differing risks of vascular disease...
  55. ncbi request reprint Liability, insurance and medical practice
    Paul Fenn
    Nottingham University Business School, Jubilee Campus, Nottingham, UK
    J Health Econ 26:1057-70. 2007
    ..These results are consistent with hospitals reacting to the incentives provided by a clinical negligence compensation system...